Home Healthcare Biotechnology mRNA Vaccines and Therapeutics Market

mRNA Vaccines and Therapeutics Market Size, Share & Trends Analysis Report By Applications (COVID-19 mRNA vaccines, Non-COVID-19 mRNA vaccines), By mRNA type (COVID-19, Non-COVID-19) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. mRNA Vaccines and Therapeutics Market Size Analysis
    1. Introduction
    2. mRNA Vaccines and Therapeutics Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
      1. COVID-19 mRNA vaccines
        1. Commercialized Vaccines
        2. Pipeline Vaccines
      2. Non-COVID-19 mRNA vaccines
        1. Oncology
        2. Infectious Diseases
        3. Other Diseases
    3. mRNA Vaccines and Therapeutics Market Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
      1. COVID-19
        1. Nucleoside-Modified mRNA (modRNA)
        2. Unmodified mRNA
        3. Self-Amplifying mRNA
      2. Non-COVID-19
        1. Nucleoside-Modified mRNA (modRNA)
        2. Unmodified mRNA
        3. Self-Amplifying mRNA)
  7. North America mRNA Vaccines and Therapeutics Market Size Analysis
    1. Introduction
    2. mRNA Vaccines and Therapeutics Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
      1. COVID-19 mRNA vaccines
        1. Commercialized Vaccines
        2. Pipeline Vaccines
      2. Non-COVID-19 mRNA vaccines
        1. Oncology
        2. Infectious Diseases
        3. Other Diseases
    3. mRNA Vaccines and Therapeutics Market Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
      1. COVID-19
        1. Nucleoside-Modified mRNA (modRNA)
        2. Unmodified mRNA
        3. Self-Amplifying mRNA
      2. Non-COVID-19
        1. Nucleoside-Modified mRNA (modRNA)
        2. Unmodified mRNA
        3. Self-Amplifying mRNA)
    4. U.S.
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
    5. Canada
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
  8. Europe mRNA Vaccines and Therapeutics Market Size Analysis
    1. Introduction
    2. mRNA Vaccines and Therapeutics Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
      1. COVID-19 mRNA vaccines
        1. Commercialized Vaccines
        2. Pipeline Vaccines
      2. Non-COVID-19 mRNA vaccines
        1. Oncology
        2. Infectious Diseases
        3. Other Diseases
    3. mRNA Vaccines and Therapeutics Market Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
      1. COVID-19
        1. Nucleoside-Modified mRNA (modRNA)
        2. Unmodified mRNA
        3. Self-Amplifying mRNA
      2. Non-COVID-19
        1. Nucleoside-Modified mRNA (modRNA)
        2. Unmodified mRNA
        3. Self-Amplifying mRNA)
    4. U.K.
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
    5. Germany
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
    6. France
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
    7. Spain
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
    8. Italy
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
    9. Russia
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
    10. Nordic
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
    11. Benelux
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
    12. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
  9. APAC mRNA Vaccines and Therapeutics Market Size Analysis
    1. Introduction
    2. mRNA Vaccines and Therapeutics Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
      1. COVID-19 mRNA vaccines
        1. Commercialized Vaccines
        2. Pipeline Vaccines
      2. Non-COVID-19 mRNA vaccines
        1. Oncology
        2. Infectious Diseases
        3. Other Diseases
    3. mRNA Vaccines and Therapeutics Market Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
      1. COVID-19
        1. Nucleoside-Modified mRNA (modRNA)
        2. Unmodified mRNA
        3. Self-Amplifying mRNA
      2. Non-COVID-19
        1. Nucleoside-Modified mRNA (modRNA)
        2. Unmodified mRNA
        3. Self-Amplifying mRNA)
    4. China
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
    5. Korea
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
    6. Japan
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
    7. India
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
    8. Australia
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
    9. Taiwan
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
    10. South East Asia
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
    11. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
  10. Middle East and Africa mRNA Vaccines and Therapeutics Market Size Analysis
    1. Introduction
    2. mRNA Vaccines and Therapeutics Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
      1. COVID-19 mRNA vaccines
        1. Commercialized Vaccines
        2. Pipeline Vaccines
      2. Non-COVID-19 mRNA vaccines
        1. Oncology
        2. Infectious Diseases
        3. Other Diseases
    3. mRNA Vaccines and Therapeutics Market Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
      1. COVID-19
        1. Nucleoside-Modified mRNA (modRNA)
        2. Unmodified mRNA
        3. Self-Amplifying mRNA
      2. Non-COVID-19
        1. Nucleoside-Modified mRNA (modRNA)
        2. Unmodified mRNA
        3. Self-Amplifying mRNA)
    4. UAE
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
    5. Turkey
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
    6. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
    7. South Africa
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
    8. Egypt
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
    9. Nigeria
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
    10. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
  11. LATAM mRNA Vaccines and Therapeutics Market Size Analysis
    1. Introduction
    2. mRNA Vaccines and Therapeutics Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
      1. COVID-19 mRNA vaccines
        1. Commercialized Vaccines
        2. Pipeline Vaccines
      2. Non-COVID-19 mRNA vaccines
        1. Oncology
        2. Infectious Diseases
        3. Other Diseases
    3. mRNA Vaccines and Therapeutics Market Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
      1. COVID-19
        1. Nucleoside-Modified mRNA (modRNA)
        2. Unmodified mRNA
        3. Self-Amplifying mRNA
      2. Non-COVID-19
        1. Nucleoside-Modified mRNA (modRNA)
        2. Unmodified mRNA
        3. Self-Amplifying mRNA)
    4. Brazil
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
    5. Mexico
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
    6. Argentina
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
    7. Chile
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
    8. Colombia
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
    9. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      3. Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
  12. Competitive Landscape
    1. mRNA Vaccines and Therapeutics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Arcturus Therapeutics Holdings Inc
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. BioNTech SE
    3. Daiichi Sankyo Company
    4. CureVac N.V
    5. Limited
    6. ethris GmbH
    7. GlaxoSmithKline plc
    8. Gennova Biopharmaceuticals Ltd
    9. Genova Biopharmaceuticals Ltd
    10. Moderna Inc
    11. Panthera Therapeutics GmbH
    12. Providence Therapeutics
    13. Silence Therapeutics
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer

List of Tables

Table 1: Global mRNA Vaccines and Therapeutics Market Size and Forecast By Regions - 2022-2034 (USD Billion)

Table 2: Global mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 3: Global mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 4: North America mRNA Vaccines and Therapeutics Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 5: North America mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 6: North America mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 7: U.S. mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 8: U.S. mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 9: Canada mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 10: Canada mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 11: Europe mRNA Vaccines and Therapeutics Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 12: Europe mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 13: Europe mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 14: U.K. mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 15: U.K. mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 16: Germany mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 17: Germany mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 18: France mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 19: France mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 20: Spain mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 21: Spain mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 22: Italy mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 23: Italy mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 24: Russia mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 25: Russia mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 26: Nordic mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 27: Nordic mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 28: Benelux mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 29: Benelux mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 30: Rest of Europe mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 31: Rest of Europe mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 32: APAC mRNA Vaccines and Therapeutics Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 33: APAC mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 34: APAC mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 35: China mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 36: China mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 37: Korea mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 38: Korea mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 39: Japan mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 40: Japan mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 41: India mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 42: India mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 43: Australia mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 44: Australia mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 45: Taiwan mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 46: Taiwan mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 47: South East Asia mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 48: South East Asia mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 49: Rest of Asia-Pacific mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 50: Rest of Asia-Pacific mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 51: Middle East and Africa mRNA Vaccines and Therapeutics Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 52: Middle East and Africa mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 53: Middle East and Africa mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 54: UAE mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 55: UAE mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 56: Turkey mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 57: Turkey mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 58: Saudi Arabia mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 59: Saudi Arabia mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 60: South Africa mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 61: South Africa mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 62: Egypt mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 63: Egypt mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 64: Nigeria mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 65: Nigeria mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 66: Rest of MEA mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 67: Rest of MEA mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 68: LATAM mRNA Vaccines and Therapeutics Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 69: LATAM mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 70: LATAM mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 71: Brazil mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 72: Brazil mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 73: Mexico mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 74: Mexico mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 75: Argentina mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 76: Argentina mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 77: Chile mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 78: Chile mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 79: Colombia mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 80: Colombia mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Table 81: Rest of LATAM mRNA Vaccines and Therapeutics Market Size and Forecast By Applications - 2022-2034 (USD Billion)

Table 82: Rest of LATAM mRNA Vaccines and Therapeutics Market Size and Forecast By mRNA type - 2022-2034 (USD Billion)

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.